Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery

Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery

Trypanosoma cruzi (T. cruzi) is the causative agent of Chagas disease (CD), which mostly affects underprivileged populations in South and Central America. The current standard of care for this disease are the two empirically discovered drugs benznidazole and nifurtimox. They show low efficacy, diffi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autore principale: Petrick, Joy Kristin
Altri autori: Klebe, Gerhard (Prof. Dr.) (Relatore della tesi)
Natura: Dissertation
Lingua:inglese
Pubblicazione: Philipps-Universität Marburg 2019
Soggetti:
Pharmakologie, Therapeutik
mevalonate
farnesyl pyrophosphate
kissing bug
Isoprenoid
FPPS
Fragment-basierte Wirkstoffforschung
FDPS
Chagas disease
Chagas
fragment based drug discovery
Protein-Kristallograph
protein cry
isoprenoid
Vernachlässigte Krankheit
Farnesylpyroposphate-Synthase
neglected disease
Pharmacology & therapeutics, prescription drugs
Accesso online:PDF Full Text
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
Lascia un commento!
Entra

Documenti analoghi